Experiment 3: Mixed vs Blocked; Dashboard Paradigm
Brigham and Women's Hospital · with National Eye Institute (NEI) · NCT06934213
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- June 1, 2024
- Record last updated
- August 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal is to look for qualitative differences in visual search behavior when one search is performed many times in a row compared to when multiple search tasks are intermixed. Four search tasks are tested. The target is the same in every task but the types of distractors change from task to task. In this version, observers get some degree of choice in what they are searching.
Being studied: Choice; Mixed trials
Conditions: Vision; Healthy; Attention
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pass Ishihara color vision test
Exclusion Criteria
- vision less than 20/25 with correction
- history of neuromuscular or visual disorders
Recruiting US locations
Brigham & Women's Hospital
Boston, MA 02115
Site contact: Jeremy M Wolfe, PhD · 617-851-1166 · jwolfe@bwh.harvard.edu
Study contacts (from the official record)
- Jeremy M Wolfe, PHD · 6178511166 · jwolfe@bwh.harvard.edu
- Cailey Tennyson, PhD · 617-525-3681 · ctennyson1@bwh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+